Trials / Terminated
TerminatedNCT02492451
Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The investigators will try to assess the effect of endometrial injury preceding the intrauterine insemination cycle on the pregnancy rates compared to cycles with luteal phase support and the control group.
Detailed description
Group 1: Endometrial biopsy is performed on days 21-24 of the spontaneous menstrual cycle proceeding the intrauterine insemination (IUI) treatment cycle. Two small biopsies are obtained from anterior and posterior walls of the uterus. Group 2: Vaginal progesterone gel is administered for luteal phase support from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy. Goup 3: Patients are undergone intrauterine insemination (IUI) cycles stimulated with gonadotropin without any intervention. The effect of endometrial injury and luteal phase progesterone support on the pregnancy rate in patients intrauterine insemination (IUI) cycles stimulated with gonadotropin will be compared in terms of biochemical pregnancy rate, clinical pregnancy rate and ongoing pregnancy rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Endometrial Injury | Endometrial injury in luteal phase of preceding cycle by pipelle canula |
| DRUG | progesterone (Crinone® %8 vaginal progesterone gel) | Luteal phase support with progesterone (Crinone® %8 vaginal progesterone gel) in IUI cycle Vaginal progesterone gel is administered from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy. |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-07-08
- Last updated
- 2016-10-20
- Results posted
- 2016-10-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02492451. Inclusion in this directory is not an endorsement.